Tokyo Olympics steeplechase finalist banned for doping

Ethiopia’s Zerfe Wondemagegn has been banned for five years after testing positive for two banned substances

The Associated Press
Monday 22 April 2024 11:44 BST
Zerfe Wondemagegn has been banned for five years
Zerfe Wondemagegn has been banned for five years (Getty Images for World Athletics)

A runner from Ethiopia who reached the 3,000-metre steeplechase final at the Tokyo Olympics has been banned for five years after testing positive for two banned substances.

Zerfe Wondemagegn, who narrowly missed out on a podium finish at last year’s World Championships, admitted breaking anti-doping rules after samples she gave flagged up traces of testosterone and another substance, EPO, which can help athletes’ blood transport more oxygen, the Athletics Integrity Unit (AIU) said in a ruling published on Monday.

Wondemagegn was eighth at the Tokyo Olympics in 2021 and fourth at the 2023 World Championships in Budapest. Two of the three samples in her case were taken while she was in Hungary for the event and she has been disqualified from the competition.

The AIU ruling said it received e-mailed testimony from a doctor saying Wondemagegn had been given EPO as medicine to treat severe anemia and a kidney infection but that it “remained satisfied” she had broken anti-doping rules. The organization added that it had received a signed admission from the athlete last week.

Wondemagegn’s is the latest in a series of doping cases in distance running.

The 2022 world champion in women’s steeplechase, Norah Jeruto, is facing a doping hearing in June, five weeks before the Paris Olympics.

World Athletics is appealing against an earlier decision to clear the runner, who was born in Kenya and competes for Kazakhstan. She has argued ulcers and a bout of COVID-19 can explain irregular blood test results.

Also on Monday, the AIU reported a three-year ban for Kenyan road runner Celestine Chepchirchir, who tested positive for testosterone.


Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies


Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in